Clinical Trials Directory

Trials / Completed

CompletedNCT01448759

Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel

Prospective Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Infusion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Institut Curie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate plasma alcohol concentration in patients receiving Paclitaxel or Docetaxel infusion.

Detailed description

In this study, there is no experimental treatment, or experimental care.

Conditions

Interventions

TypeNameDescription
OTHERblood samplingOther: Blood sampling 10mL of peripherical blood will be collected specially for the study. It's an additional blood sampling compare to the normal follow up of the patient.

Timeline

Start date
2011-10-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2011-10-07
Last updated
2015-04-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01448759. Inclusion in this directory is not an endorsement.